'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Vilin Bio Med Limited
VILINBIO (NSE) · ISIN INE0L4V01013 · Pharmaceuticals · listed 2023
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹28.37 cr | ₹0.21 cr | ₹34.94 cr |
| 30 Sep 2025 standalone | ₹23.22 cr | ₹0.46 cr | ₹25 cr |
| 31 Mar 2025 standalone | ₹23.06 cr | ₹2.57 cr | ₹27.73 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 56.65% | 0.13% | 0.00% | 43.35% |
Latest filings
- Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on September 15, 2026. 15 September 2026 · NSE
- Annual Report FY2025-26 (Revised) 19 August 2026 · NSE
- Annual Report FY2025-26 (New) 10 August 2026 · NSE
- Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on August 10, 2026. 10 August 2026 · NSE
- VILINBIO: Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on June 27, 2026. 27 June 2026 · NSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.